Brown Advisory’s PAVmed PAVM Stock Holding History

Brown Advisory’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-22	Closed	-$16K	–	1316
2018 Q1	$16K	Hold	22	–	–	﹤0.01%	1168
2017 Q4	$23K	Hold	22	–	–	﹤0.01%	1215
2017 Q3	$54K	Hold	22	–	–	﹤0.01%	1172
2017 Q2	$45K	Hold	22	–	–	﹤0.01%	1199
2017 Q1	$50K	Buy	+22	New	+$59.3K	﹤0.01%	1150

Other funds holding PAVM

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory's PAVM Position: Q2 2018 in Review

Brown Advisory sold out of PAVmed (PAVM) in Q2 2018, closing a stake of 22 shares — an estimated $16K sold.

Brown Advisory first reported a position in PAVM in Q1 2017 and held it in 5 quarters. The position peaked at $54K in Q3 2017. 9 funds tracked by Wall St. Rank hold PAVM as of Q2 2018.

Brown Advisory reported no remaining PAVmed position as of Q2 2018 after selling out during the quarter.
Brown Advisory sold 22 PAVmed shares in Q2 2018, an estimated $16K.
Brown Advisory first reported a position in PAVmed in Q1 2017 and held it in 5 quarters.
Brown Advisory's PAVmed position peaked at $54K in Q3 2017.
9 funds tracked by Wall St. Rank held PAVmed as of Q2 2018.

Based on Brown Advisory's 13F filing for Q2 2018, filed 10 Aug 2018.